ZR2 Bioenergy Ltd
Incorporated in 1939, ZR2 Bioenergy Limited is in the business of Ethanol and bioenergy products.[1]
- Market Cap ₹ 227 Cr.
- Current Price ₹ 142
- High / Low ₹ 437 / 90.0
- Stock P/E 227
- Book Value ₹ 87.9
- Dividend Yield 0.08 %
- ROCE 0.70 %
- ROE 0.72 %
- Face Value ₹ 1.00
Pros
- Company is almost debt free.
Cons
- Earnings include an other income of Rs.1.87 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| 1.16 | 1.49 | 0.00 | |
| 1.11 | 1.87 | 0.68 | |
| Operating Profit | 0.05 | -0.38 | -0.68 |
| OPM % | 4.31% | -25.50% | |
| 0.27 | 0.64 | 1.87 | |
| Interest | 0.00 | 0.01 | 0.00 |
| Depreciation | 0.00 | 0.04 | 0.21 |
| Profit before tax | 0.32 | 0.21 | 0.98 |
| Tax % | -21.88% | 52.38% | -3.06% |
| 0.39 | 0.09 | 1.00 | |
| EPS in Rs | 2.44 | 0.25 | 0.63 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -100% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 1150% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 75% |
| 3 Years: | 30% |
| 1 Year: | -63% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 1% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Equity Capital | 0.36 | 0.36 | |
| Reserves | 138.99 | 139.61 | |
| 0.00 | 0.00 | ||
| 0.15 | 1.34 | ||
| Total Liabilities | 139.50 | 141.31 | |
| 0.50 | 0.31 | ||
| CWIP | 118.96 | 120.17 | |
| Investments | 0.00 | 0.00 | |
| 20.04 | 20.83 | ||
| Total Assets | 139.50 | 141.31 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| 0.91 | 31.05 | ||
| 0.19 | -116.66 | ||
| 0.00 | 100.39 | ||
| Net Cash Flow | 1.10 | 14.78 | |
| Free Cash Flow | 0.91 | -88.44 | |
| CFO/OP | 1,780% | -8,171% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Debtor Days | 4.90 | ||
| Inventory Days | 0.00 | 0.00 | |
| Days Payable | |||
| Cash Conversion Cycle | 4.90 | ||
| Working Capital Days | 161.68 | ||
| ROCE % | 0.70% |
Insights
In beta| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of Permanent Employees Count ・Standalone data |
|
||||||||||
| Capital Work-in-Progress (Biorefinery Acquisition) Lakhs |
|||||||||||
| Number of Subsidiaries Count ・Standalone data |
|||||||||||
| Land Parcels for Bioenergy (Area) Acres ・Standalone data |
|||||||||||
Extracted by Screener AI
Documents
Announcements
-
Board Meeting Outcome for Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Year Ended March 31 2026.
29 May - Board approved FY26 audited standalone and consolidated results; unmodified audit opinion, trading window opens after 48 hours.
- Audited Financial Results For The Quarter Ended 31St March, 2026 29 May
-
Clarification Sought From The Company On Significant Movement In Price
28 May - Company clarified recent share price movement is market-driven; no undisclosed material information.
-
Clarification Sought From The Company On Significant Movement In Price
28 May - Company clarified no undisclosed material event behind share price movement.
-
Board Meeting Intimation for Intimation Of 01/2026-27 Board Meeting For Consideration Of Audited Financial Results For The Quarter Ended March 31, 2026.
26 May - Board to meet on May 29, 2026 to approve audited Q4 and FY26 financial results.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1]
ZR2BEL is in the business of bioenergy and the waste-to-energy economy, and produces
biofuels, hydrogen and electricity, carbon credits and other derivative products from agri waste, biomass, sugar cane, grain, corn, maize, waste and RDF.